Biogen (BIIB) Intangibles (2009 - 2026)
Biogen (BIIB) posted Intangibles of $13.5 billion for Q2 2026, up 49.29% on a QoQ basis from $9.1 billion in Q1 2026, and up 42.77% year-over-year from $9.5 billion in Q2 2025.
Analysis
Biogen (BIIB) Intangibles (2009 - 2026) Analysis & Trends
Biogen has reported Intangibles for 18 years, with the latest figure at $13.5 billion in Q2 2026.
- On a quarterly basis, Intangibles rose 42.77% year-over-year to $13.5 billion in Q2 2026; TTM through Jun 2026 was $13.5 billion, a 42.77% increase from a year earlier, with the FY2025 full-year figure at $9.2 billion, down 5.29% from the prior year.
- Intangibles was $13.5 billion for Q2 2026 at Biogen, up from $9.1 billion in the prior quarter.
- The five-year high for Intangibles was $13.5 billion in Q2 2026, with the low at $1.8 billion in Q2 2023.
- Average Intangibles over 5 years is $6.9 billion, with a median of $8.3 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Intangibles decreased 28.02% in 2022, then soared 363.46% in 2024.
- Over 5 years, Intangibles stood at $1.9 billion in 2022, then soared by 352.03% to $8.4 billion in 2023, then gained by 15.88% to $9.7 billion in 2024, then retreated by 5.29% to $9.2 billion in 2025, then jumped by 47.26% to $13.5 billion in 2026.
- The last three Intangibles figures came in at $13.5 billion (Q2 2026), $9.1 billion (Q1 2026), and $9.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 20.49 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 14.03 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 412.80 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.31 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 266.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 13.52 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn | 93.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.52 Bn |
| Mar 31, 2026 | 9.05 Bn |
| Dec 31, 2025 | 9.18 Bn |
| Sep 30, 2025 | 9.33 Bn |
| Jun 30, 2025 | 9.47 Bn |
| Mar 31, 2025 | 9.58 Bn |
| Dec 31, 2024 | 9.69 Bn |
| Sep 30, 2024 | 9.81 Bn |
| Jun 30, 2024 | 8.23 Bn |
| Mar 31, 2024 | 8.28 Bn |
| Dec 31, 2023 | 8.36 Bn |
| Sep 30, 2023 | 7.34 Bn |
| Jun 30, 2023 | 1.78 Bn |
| Mar 31, 2023 | 1.81 Bn |
| Dec 31, 2022 | 1.85 Bn |
| Sep 30, 2022 | 2.01 Bn |
| Jun 30, 2022 | 2.08 Bn |
| Mar 31, 2022 | 2.15 Bn |
| Dec 31, 2021 | 2.22 Bn |
| Sep 30, 2021 | 2.29 Bn |